Beam Therapeutics Inc.

About Beam Therapeutics Inc.

Beam Therapeutics is a biotechnology company focused on breaking new ground to advance science with the potential to change lives through precision genetic medicines.

Products & Services

Base Editing:An emerging class of investigational precision genetic medicines designed to overcome limitations of existing approaches and expand the potential of genetic medicine.

Specialties

Base Editing Precision Genetic Medicines Gene-Based Editing Base editing Precision genetic medicines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2026-02-24 FD: 2026-02-24	1 investors
2	RT: Underwritten Offering T: - FT: Underwritten Offering	A: 500000000 MR: - FA: approximately $500.0 million FAN: 500000000	D: 2025-03-10 FD: 2025-03-10	5 investors

Debt Latest

2026-02-24

$500.0M

1 investor (Pro only)

Underwritten Offering 2025-03-10

$500.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Evans

Chief Executive Officer and Board Member

G

Giuseppe Ciaramella

President

A

Amy Simon

Chief Medical Officer

S

Sravan Emany

Chief Financial Officer

S

Susan O’Connor

Chief Human Resources Officer

J

John Lo

Chief Commercial Officer

View 18 more team members with Pro

Unlock Full Team Directory

Recent News